RSS Amplifier

Podcast

Neurology Today in 5

Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today highlights the most noteworthy and newsworthy neurology stories in the issue.

neurotodayonline.comSource feed ↗10 episodes

Live Last read · last published · next check

Written by

Latest episodes

Saves to your Listen queue, to pick up on another day or another device.

American Board of Psychiatry and Neurology Academic Pathway, EpiWatch App, Multiplexed MR Scanning

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a pilot American Board of Psychiatry and Neurology Academic Pathway, a study of the EpiWatch app, and a new approach to magnetic resonance scanning.

Play

Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.

Play

OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology

In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology.

Play

Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about appointment wait times for commercially insured patients, post-traumatic headache severity in children with a family history of migraine, and the FDA approval of a drug for Alzheimer's agitation.

Play

Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology.

Play

New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.

Play

Neurology Match Day Growth, Diabetes and Dementia Risk, Public Health Discourse

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the increase in neurology residency matches this year, the risk of dementia in people with Type 1 diabetes, and the role of neurologists in the public health conversation.

Play

Academic Jobs for Fellowship Graduates, Complex Neuromuscular Treatments, New Stroke Guideline

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the academic job market for fellowship graduates, the challenges of today's complex neuromuscular therapies, and the changes made in a new stroke guideline.

Play

Acetaminophen Use During Pregnancy, Air Pollution and Motor Neuron Disease, Fremanezumab for Pediatric Migraine

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about acetaminophen use during pregnancy, the link between air pollution and motor neuron disease risk, and the use of fremanezumab for pediatric migraine.

Play

ACGME neurocritical care accreditation, Jamaica hurricane aftermath, rituximab for multiple sclerosis

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about ACGME neurocritical care accreditation, how neurologists in Jamaica are recovering from hurricane damage, and the use of rituximab maintenance dosing in multiple sclerosis.

Play